source
- Former Orbital scientists launch ParcelBio with $13 million seed round to boost mRNA therapy durabilityTwo former Orbital Therapeutics scientists, Chris Carlson and David Weinberg, have founded a new company called ParcelBio. The startup aims to address a technical limitation that has hindered the…
- Experts preview top HR+ and HER2+ breast cancer abstracts ahead of ASCO 2026Preparations are under way for the 2026 ASCO Annual Meeting, and breast cancer updates are generating strong interest among clinicians. Leading oncologists including Dr. Yara Abdou of UNC, Dr. VK…